Rani Therapeutics Holdings Inc - Ordinary Shares Class A

NASDAQ:RANI   3:34:20 PM EDT
10.57
0.00 (+0.05%)
Earnings Announcements

Rani Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/29/2022 20:31 GMT
Rani Therapeutics Holdings Inc - Ordinary Shares Class A (RANI) - Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update.
Cash and Cash Equivalents As of December 31, 2021 Were $117.5 Million, Compared to $73.1 Million As of December 31, 2020.
Rani Therapeutics - Sees Cash, Cash Equivalents Balance to Be Sufficient to Fund Operating Expenses, Capex Requirements at Least Until End of 2023.
Qtrly Net Loss per Class A Common Share Attributable to Rani Therapeutics Holdings, Inc, Basic and Diluted $0.27.
Q4 Earnings per Share View $-0.50 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.33 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.91

More details on our Analysts Page.